GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (MEX:NVAX) » Definitions » Market Cap

Novavax (MEX:NVAX) Market Cap : MXN23,661 Mil (As of Mar. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Novavax Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Novavax's share price for the quarter that ended in Dec. 2024 was MXN164. Novavax's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 160 Mil. Therefore, Novavax's market cap for the quarter that ended in Dec. 2024 was MXN26,309 Mil.

Novavax's quarterly market cap increased from Jun. 2024 (MXN36,615 Mil) to Sep. 2024 (MXN39,877 Mil) but then declined from Sep. 2024 (MXN39,877 Mil) to Dec. 2024 (MXN26,309 Mil).

Novavax's annual market cap declined from Dec. 2022 (MXN17,208 Mil) to Dec. 2023 (MXN11,357 Mil) but then increased from Dec. 2023 (MXN11,357 Mil) to Dec. 2024 (MXN26,309 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Novavax's Enterprise Value for Today is MXN9,625 Mil.


Novavax Market Cap Historical Data

The historical data trend for Novavax's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Market Cap Chart

Novavax Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157,517.88 222,719.99 17,208.00 11,357.18 26,309.04

Novavax Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,357.18 11,277.57 36,615.04 39,876.85 26,309.04

Competitive Comparison of Novavax's Market Cap

For the Biotechnology subindustry, Novavax's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novavax's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novavax's Market Cap distribution charts can be found below:

* The bar in red indicates where Novavax's Market Cap falls into.


;
;

Novavax Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Novavax's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=MXN164*160.421
=MXN26,309

Novavax's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=MXN164*160.421
=MXN26,309

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novavax  (MEX:NVAX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Novavax Market Cap Related Terms

Thank you for viewing the detailed overview of Novavax's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Novavax Business Description

Address
700 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.